Fujirebio Europe is a leading R&D-driven brand that focuses on developing innovative technologies and unique biomarkers with significant clinical value. With over 50 years of experience in the field, Fujirebio has established itself as a pioneer and trusted partner in the diagnostics industry. Their extensive range of products and services includes fully automated testing kits, instruments such as LUMIPULSE® G and TENDIGO™, and software solutions like LIRAS® for reading and interpretation.

They also offer a wide range of controls, raw materials, and testing solutions for various diseases and disorders including autoimmune diseases, diabetes, neurodegeneration, and infectious diseases. Through their collaborations and acquisitions of notable industry players like Centocor Diagnostics, CanAg Diagnostics, and Innogenetics, Fujirebio has further enhanced their expertise in different clinical areas. Committed to advancing healthcare, Fujirebio combines expertise, experience, and cutting-edge technology to create new value in healthcare and contribute to the future of medical care